Why the Brain Always — Lights Up on PET

No. Diffuse cortical uptake is the standard way radiologists describe normal brain activity on a PET scan. The cortex is the outer layer of the brain, and it uses glucose continuously, so it always lights up. The word diffuse tells you the uptake is spread evenly across the whole brain — exactly what normal looks like. A brain metastasis, if visible at all on PET, would appear as a localised area of higher uptake standing out from the background. Your oncologist can walk you through what your specific report found.

Not on the basis of PET alone. Because the brain's background activity is so high, PET has limited sensitivity for brain metastases — recognised in guidance from NCCN and ESMO. A normal-looking brain on PET cannot confirm there is no tumour there. Whether you need a brain MRI to be more certain depends on your cancer type and whether you have symptoms. That is a conversation to have with your oncologist, not a conclusion to draw from the PET report itself.

For some cancer types, yes — brain metastases can develop silently, without headache or any neurological change, until they reach a certain size. NCCN guidelines recommend routine brain MRI for staging in several cancers, including non-small cell lung cancer and melanoma. For other cancers the decision depends on stage and risk. Your oncologist will decide based on your specific diagnosis. If you are unsure whether a brain MRI is part of your staging plan, ask at your next appointment rather than assuming it has been arranged.

The contrast agent used in brain MRI is typically a gadolinium-based compound, given through a small cannula in the arm. The scan itself is loud but not painful, and most people tolerate it without difficulty. If you have kidney disease, your team will check kidney function beforehand, because gadolinium is cleared through the kidneys. Allergic reactions are uncommon. Tell your team about any previous contrast reactions, kidney problems, or metal implants before the scan is booked, as some implants are not compatible with MRI.

Contrast-enhanced MRI is considerably more sensitive than PET for detecting brain metastases, which is why NCCN and ESMO recommend it for this purpose. However, no imaging test detects every lesion at every size. Very small deposits may not be visible on any scan at a given point in time. If new neurological symptoms develop after a clear MRI, report them promptly rather than waiting for your next scheduled scan. Your oncologist will advise on how often imaging is appropriate for your situation.

In most cases, yes. The two scans use different technologies and do not interfere with each other. PET-CT requires fasting and involves a radioactive tracer; MRI uses a magnetic field and a separate contrast agent. Scheduling them on the same day reduces trips and speeds up the staging process. Your team or the imaging coordinator will arrange the order and timing. CION coordinates PET-CT imaging with partner imaging centres; your team will advise on where brain MRI should be arranged if it is needed.